secwatch.observer — SEC 8-K summary
======================================

Issuer:     InMed Pharmaceuticals Inc. (INM)
CIK:        0001728328
Form:       8-K
Filed at:   2024-09-26T23:59:59+00:00
Accession:  0001213900-24-082247
Event type: other
Sentiment:  neutral
Materiality: 0.20
Item codes: 8.01, 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

InMed sets 2024 annual meeting for Dec 18; record date Oct 21
-------------------------------------------------------------

- Annual general meeting scheduled for December 18, 2024.
- Record date for notice and voting is October 21, 2024.
- Meeting will be held for common shareholders (ISIN CA4576376012).
- Issuer uses notice-and-access for both beneficial and registered holders.
- Odyssey Trust Company acts as agent for the issuer in the filing.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1728328/000121390024082247/0001213900-24-082247-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1728328/000121390024082247/ea0215833-8k_inmed.htm
  HTML page:      https://secwatch.observer/filing/0001213900-24-082247

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer